C. Muñoz

Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

D. Vidal, J. Carrascosa, M. Alsina, 2018, The Journal of dermatological treatment.

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis

J. Romaní, J. Carrascosa, C. Ferrándiz, 2018, Cellular & Molecular Immunology.

Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis.

J. Romaní, J. Carrascosa, C. Ferrándiz, 2017, Journal of dermatological science.

Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

F. Vanaclocha, D. Vidal, J. Carrascosa, 2013, Actas dermo-sifiliograficas.

Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group

D. Vidal, I. Belinchón, G. Carretero, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis

J. Romaní, J. Carrascosa, C. Ferrándiz, 2018, Cellular & Molecular Immunology.

Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

F. Vanaclocha, D. Vidal, I. Belinchón, 2013, Actas Dermo-Sifiliográficas.